menu search

J&j (jnj) discontinues hiv vaccine phase iii mosaico study

J&J (JNJ) discontinues phase iii study on its investigational HIV vaccine regimen, which shows that the...

January 19, 2023, 9:02 am

Eurusd long correction likely to end near 1.122

In the long term, the EURUSD currency is expected to form a bearish cycle impulse consisting of sub-waves I-II-III-IV-V. Most likely, the market is in...

January 19, 2023, 8:16 am

Moderna (mrna) up on upbeat data from phase iii study on rsv jab

Data from a late-stage study showed that Moderna's (MRNA) RSV vaccine was 83.7% effective at preventing at least two symptoms in adults aged 60 and ol...

January 18, 2023, 12:03 pm

(spac) special purpose acquisition investigation: paya holdings, perella weinberg, porch.com, rush street, contact shareholder rights law firm johnson fistel

SAN DIEGO, Jan. 15, 2023 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connecti...

January 15, 2023, 1:43 pm

Goldman closes latest mezzanine debt fund at $15.2 bln

Goldman Sachs Group Inc. GS, +1.99% said Thursday it drew in $15.2 billion in capital for West Street Mezzanine Partners VIII, a debt fund. “We beli...

January 12, 2023, 8:19 am

Gold elliott wave impulse move near complete

Short term cycle from 11.23.2022 low remains in progress as a 5 waves impulse Elliott Wave. Up from 11.23.2022 low, wave ((i)) ended at 1833.29 and pu...

January 11, 2023, 6:20 am

L+m development partners, triangle equities and the bluestone organization close $95.7 million on beach green dunes iii

L+M Development Partners (L+M), in partnership with Triangle Equities and The Bluestone Organization, closed on $95.7 million in financing for Beach G...

January 11, 2023, 1:59 am

Inventrust properties corp. announces fourth quarter 2022 earnings release and conference call dates

DOWNERS GROVE, III.--( BUSINESS WIRE )--InvenTrust Properties Corp. (“InvenTrust” or the “Company”) (NYSE: IVT) today announced that it will r...

January 10, 2023, 4:38 pm

Chinook therapeutics: best biotech for kidney disease exposure, with catalysts

2023 should be a year of progress on kidney disease, with multiple catalysts lined up from multiple companies. Chinook Therapeutics, Inc. has the best...

January 6, 2023, 12:21 pm

Spx500 impulsive trend hits 5,000!

The SPX500 index seems to form a wave V of a bullish impulse consisting of cycle sub-waves I-II-III-IV-V. The cycle correction wave IV ended in the se...

January 6, 2023, 7:31 am

Geron (gern) up on imetelstat data on myelodysplastic syndromes

Geron (GERN) posts positive top-line data from the phase iii IMerge study investigating its lead candid...

January 5, 2023, 3:48 pm

G-iii apparel, bioventus, beyond meat, invivyd shareholder update: johnson fistel encourages shareholders with losses to contact the firm regarding class action investigation

SAN DIEGO, Jan. 05, 2023 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP is investigating G-III Apparel Group Ltd. (NASDAQ: GIII)...

January 5, 2023, 1:27 pm

Astrazeneca: has the market factored in the full value of potential cancer blockbuster?

A phase iii clinical trial of a lung cancer drug developed by AstraZeneca PLC (LSE:AZN) and Daiichi San...

January 5, 2023, 5:58 am

Astrazeneca dato-dxd tl01 study data expected to be a high positive "which should unlock multi-blockbuster potential" - analysts

Ahead of Dato-DXd TL01 study data, expected to be published by AstraZeneca PLC (LSE:AZN) by the end of Q1 2023, analysts at JPMorgan see a high posit...

January 5, 2023, 5:05 am

Scorpio tankers inc. announces repurchases of shares, purchase of call options by the president of the company, a new credit facility, and participation in upcoming investor events

MONACO, Jan. 04, 2023 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”), announced today that (i) it...

January 4, 2023, 10:44 pm

Is information services group (iii) stock undervalued right now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...

January 4, 2023, 11:17 am

Merrimack still has significant arbitrage potential

In December 2022, MACK got positive clinical results for its Phase iii clinical trial of Onivyde in fir...

January 4, 2023, 10:33 am

P3 health partners to present at the 41st annual j.p. morgan healthcare conference

HENDERSON, Nev.--( BUSINESS WIRE )-- P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led popu...

January 3, 2023, 5:00 pm

Iii or acn: which is the better value stock right now?

III vs. ACN: Which Stock Is the Better Value Option?...

January 3, 2023, 12:47 pm

Hikma pharmaceuticals launches generic version of narcolepsy treatment xyrem in us

Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) said it has launched an authorised generic version of Jazz Pharmaceuticals' Xyrem (sodium oxybate) ora...

January 3, 2023, 4:11 am


Search within

Pages Search Results: